Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.72%40.22B | 27.35%36.99B | 31.89%11.81B | 39.66%9.78B | 18.21%7.9B | 17.11%7.51B | -14.97%29.05B | -3.38%8.95B | -31.41%7B | -12.40%6.68B |
| Cost of revenue | 8.73%31.96B | 25.30%29.39B | 35.47%9.51B | 34.63%7.68B | 18.12%6.26B | 9.37%5.94B | -15.48%23.46B | -7.78%7.02B | -34.02%5.71B | -12.85%5.3B |
| Gross profit | 8.65%8.26B | 35.97%7.6B | 18.89%2.3B | 61.78%2.1B | 18.57%1.64B | 60.06%1.57B | -12.78%5.59B | 16.88%1.93B | -16.99%1.3B | -10.63%1.38B |
| Operating expense | 4.31%5.01B | 3.90%4.8B | 14.56%1.33B | 0.16%1.13B | -1.05%1.19B | 1.94%1.15B | 3.31%4.62B | -0.22%1.16B | 3.22%1.13B | 8.93%1.2B |
| Operating profit | 16.11%3.25B | 189.46%2.8B | 25.46%963.62M | 484.02%963.94M | 148.86%450.07M | 381.86%417.84M | -50.03%965.75M | 57.88%768.09M | -64.55%165.05M | -59.23%180.86M |
| Net non-operating interest income (expenses) | 12.30%79.34M | 17.87%70.65M | 3.38%34.85M | 41.79%12.19M | 44.66%13.21M | 22.36%10.41M | 11.59%59.94M | 30.13%33.71M | 15.11%8.6M | -9.27%9.13M |
| Non-operating interest income | 11.99%79.98M | 17.60%71.42M | 2.55%35.05M | 43.11%12.75M | 45.12%13.07M | 22.20%10.55M | 10.60%60.73M | 29.18%34.18M | 9.89%8.91M | -10.53%9.01M |
| Non-operating interest expense | -16.43%641K | -2.54%767K | -56.54%206K | ---- | ---- | 11.81%142K | -34.20%787K | -14.90%474K | ---- | ---- |
| Net investment income | 60.85%77.04M | -3.46%47.89M | 70.04%-3.98M | 33.63%25.88M | -122.12%-3.33M | 3.00%29.33M | -14.61%49.61M | -341.04%-13.3M | -12.13%19.37M | 312.23%15.06M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 44.16%318.36M | 0 | 0 | |||||
| Income from associates and other participating interests | -45.55%77.15M | -49.69%141.69M | -595.09%-182.34M | -19.53%103.27M | 71.77%125.29M | 119.21%95.47M | 45.73%281.65M | 3,771.88%36.83M | 140.42%128.33M | -11.62%72.94M |
| Special income (charges) | 38.90%-47.59M | -848.21%-77.89M | -482.88%-8.52M | -4,077.50%-38.43M | -170.26%-15.74M | -310.95%-15.19M | -120.73%-8.21M | -95.16%2.23M | 69.38%-920K | -358.87%-5.82M |
| Less:Other special charges | -29.69%47.59M | 724.03%67.69M | 24.66%-1.68M | 5,186.20%48.63M | -4.91%5.54M | 310.95%15.19M | 120.73%8.21M | 95.16%-2.23M | -69.38%920K | 358.87%5.82M |
| Less:Write off | --0 | --10.2M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | 208.53%90.08M | -76.23%29.2M | -66.57%15.92M | -109.62%-2.96M | -21.42%10.15M | -80.66%6.08M | 113.19%122.82M | 203.46%47.63M | -57.80%30.82M | 348.37%12.92M |
| Income before tax | 17.12%3.52B | 68.00%3.01B | -6.36%819.55M | 202.89%1.06B | -3.94%579.66M | 1,461.33%543.93M | -29.97%1.79B | 18.63%875.18M | -43.21%351.24M | 10.34%603.45M |
| Income tax | 17.41%1.03B | 93.06%877.73M | 6.40%197.97M | 406.42%249.53M | -23.25%128.64M | 483.29%301.59M | -34.47%454.65M | 24.73%186.07M | -63.99%49.27M | -9.00%167.6M |
| Net income | 17.00%2.49B | 59.46%2.13B | -9.80%621.57M | 169.68%814.35M | 3.48%451.02M | 364.39%242.35M | -28.29%1.34B | 17.08%689.11M | -37.31%301.97M | 20.16%435.86M |
| Net income continuous operations | 17.00%2.49B | 59.46%2.13B | -9.80%621.57M | 169.68%814.35M | 3.48%451.02M | 364.39%242.35M | -28.29%1.34B | 17.08%689.11M | -37.31%301.97M | 20.16%435.86M |
| Noncontrolling interests | 24.70%88.1M | 4.34%70.65M | 22.19%22.09M | 1.35%15.29M | -27.71%16.05M | 39.50%17.23M | 39.15%67.71M | 78.71%18.08M | -13.16%15.09M | 139.67%22.2M |
| Net income attributable to the company | 16.74%2.4B | 62.41%2.06B | -10.66%599.49M | 178.53%799.06M | 5.15%434.97M | 316.44%225.12M | -30.10%1.27B | 16.00%671.04M | -38.21%286.89M | 17.03%413.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 16.74%2.4B | 62.41%2.06B | -10.66%599.49M | 178.53%799.06M | 5.15%434.97M | 316.44%225.12M | -30.10%1.27B | 16.00%671.04M | -38.21%286.89M | 17.03%413.65M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 16.55%149.22 | 63.83%128.03 | -10.17%37.27 | 179.73%49.68 | 7.25%27.06 | 321.48%14.02 | -29.22%78.15 | 17.87%41.49 | -37.15%17.76 | 17.29%25.23 |
| Diluted earnings per share | 16.55%149.22 | 63.83%128.03 | -10.20%37.2581 | 179.63%49.6617 | 7.25%27.06 | 321.48%14.02 | -29.22%78.15 | 17.87%41.49 | -37.15%17.76 | 17.29%25.23 |
| Dividend per share | 50.00%60 | 33.33%40 | 66.67%25 | 0 | 0.00%15 | 0 | -11.76%30 | -21.05%15 | 0 | 0.00%15 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |